Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1989 1
1991 1
1992 1
1994 4
1996 1
1997 1
1998 2
1999 3
2000 4
2001 4
2002 6
2003 2
2004 2
2005 1
2006 5
2013 1
2016 3
2017 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
The effect of acarbose on the pharmacokinetics of rosiglitazone.
Miller AK, Inglis AM, Culkin KT, Jorkasky DK, Freed MI. Miller AK, et al. Among authors: freed mi. Eur J Clin Pharmacol. 2001 May;57(2):105-9. doi: 10.1007/s002280100275. Eur J Clin Pharmacol. 2001. PMID: 11417440 Clinical Trial.
Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism.
Wang A, Holcslaw T, Bashore TM, Freed MI, Miller D, Rudnick MR, Szerlip H, Thames MD, Davidson CJ, Shusterman N, Schwab SJ. Wang A, et al. Among authors: freed mi. Kidney Int. 2000 Apr;57(4):1675-80. doi: 10.1046/j.1523-1755.2000.00012.x. Kidney Int. 2000. PMID: 10760103 Free article. Clinical Trial.
Systemic exposure to rosiglitazone is unaltered by food.
Freed MI, Allen A, Jorkasky DK, DiCicco RA. Freed MI, et al. Eur J Clin Pharmacol. 1999 Mar;55(1):53-6. doi: 10.1007/s002280050592. Eur J Clin Pharmacol. 1999. PMID: 10206085 Clinical Trial.
43 results